Friday, Dec 27, 2024 · SEC filings

What the smart money revealed on Dec 27

Real insider buys13insiders · $9.47M
Real insider sales31insiders · $43.3M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

212 insider filings came in. We hid 35 planned (10b5-1) sellers and 102 people whose filings were routine, like grants and tax withholding.

group

4 insiders at Quoin Pharmaceuticals (QNRX) bought $600K of stock

Roles: CEO, CFO, COO, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Dec 23
$600K
trending_up

Prospect Capital (PSEC) CEO John Barry bought $8.58M

2M shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 6 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 0 of 6 beat Traded Dec 24
$8.58M
trending_up

Oklo (OKLO) Director Richard Kinzley bought $99.8K

5,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Dec 23
$99.8K
trending_up

Greif (GEF) EVP and CFO Lawrence Hilsheimer bought $74.3K

1,075 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 6 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 4 of 6 beat Traded Dec 26
$74.3K
trending_up

Lakeland Industries (LAKE) Director Nikki Hamblin bought $51.2K

2,220 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Dec 23
$51.2K
trending_down

Broadcom (AVGO) President and CEO Hock Tan sold $10.8M

Not marked as a planned 10b5-1 sale. Sold 5% of the shares they held directly. Still holds 842,836 shares.

Real sale Form 4 Traded Dec 24
$10.8M
trending_down

Nexstar Media Group (NXST) CEO Perry Sook sold $8.45M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 674,694 shares directly.

Real sale Form 4 Traded Dec 24–26
$8.45M
trending_down

Intergroup (INTG) Director John Love sold $149K

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Dec 20
$149K
Show 5 more real buys
Show 28 more real sales
RCAT Red Cat · CTO George Matus · Traded Dec 24–26
$5.29M
AVGO Broadcom · Chief Legal and Corp Affairs Ofc Mark Brazeal · Traded Dec 24
$4.82M
WMT Walmart · President and CEO C. Douglas McMillon · Traded Dec 26
$2.69M
IOT Samsara · President Lara Caimi · Traded Dec 23
$1.96M
CDMO Avid Bioservices · President and CEO Nicholas Green · Traded Dec 26
$1.78M
GTLB Gitlab · Director Susan Bostrom · Traded Dec 24
$1.2M
KMX CarMax · SVP Jon Daniels · Traded Dec 26
$853K
PFSI PennyMac Financial Services · Director Doug Jones · Traded Dec 26
$813K
STRZ Lions Gate Entertainment · CEO Jon Feltheimer · Traded Dec 26
$720K
RPC P10 · Director David McCoy · Traded Dec 23
$707K
PLAB Photronics · CEO Kang Lee · Traded Dec 24
$420K
CTRN Citi Trends · Director Jonathan Duskin · Traded Dec 26
$317K
CMT Core Molding Technologies · CEO David Duvall · Traded Dec 24–26
$309K
CDMO Avid Bioservices · CFO Daniel Hart · Traded Dec 26
$279K
CRK Comstock Resources · Director Elizabeth Davis · Traded Dec 24–27
$274K
PLAB Photronics · SVP and GM of FPD Ops Han Park · Traded Dec 24
$268K
PLAB Photronics · Director Walter Fiederowicz · Traded Dec 24
$240K
SHCO Soho House · COO Thomas Collins · Traded Dec 24–27
$167K
CDMO Avid Bioservices · Chief Commercial Officer Matthew Kwietniak · Traded Dec 26
$164K
KEQU Kewaunee Scientific · President Thomas Hull III · Traded Dec 26
$126K
NXST Nexstar Media Group · Director Charles McMillen · Traded Dec 26
$120K
BINI Mullen Automotive · Director Ignacio Novoa · Traded Oct 13–Mar 21
$114K
ESRT Empire State Realty Trust · EVP Thomas Durels · Traded Dec 24
$101K
CGEM Cullinan Therapeutics · President and CEO Nadim Ahmed · Traded Dec 24
$99.7K
CDMO Avid Bioservices · Chief Operations Officer Richard Richieri · Traded Dec 26
$47K
BFLY Butterfly Network · CTO Andrei Stoica · Traded Dec 24
$10K
TOL Toll Brothers · Director Christine Garvey · Traded Dec 24
$2.66K
APLS Apellis Pharmaceuticals · Chief Development Officer Jeffrey Eisele · Traded Dec 23
$2.08K

13F season

Holdings as of Sep 30, 2024 were due Nov 14

58 funds have filed. 54 filed for the quarter before.

Biggest real insider buys, Dec 21–27

Open-market buys by officers and directors, filed in the 7 days up to Dec 27.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist